Cliff Stocks: Founder and CEO of OncoResponse

Portrait of Cliff Stocks

Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

Steinway Annual Report cover detail
Steinway Musical Instruments

Extending Our Reach

Alexion Pharmaceuticals

Rare Heroes

Regeneron Annual Report Cover Detail
Regeneron

Annual Report